Powder: -20°C for 3 years | In solvent: -80°C for 1 year
PCAF-IN-2 (compound 17) is a potent inhibitor of PCAF with an IC50 of 5.31 µM. PCAF-IN-2 exhibits anti-tumor activity. CAF-IN-2 induces cell apoptosis and arrest the cell cycle at the G2/M phase[1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 766.00 | |
50 mg | 6-8 weeks | $ 996.00 | |
100 mg | 6-8 weeks | $ 1,490.00 |
Description | PCAF-IN-2 (compound 17) is a potent inhibitor of PCAF with an IC50 of 5.31 µM. PCAF-IN-2 exhibits anti-tumor activity. CAF-IN-2 induces cell apoptosis and arrest the cell cycle at the G2/M phase[1]. |
In vitro | PCAF-IN-2 exhibits anti-tumour activity with IC 50 s of 3.06, 5.69, 7.56, 2.83 μM for HePG2, MCF-7, PC3, HCT-116 cells, respectively [1]. PCAF-IN-2 (10 μM; 24 h) induces cell apoptosis and arrest the cell cycle at the G2/M phase in HePG2 cells [1]. |
Molecular Weight | 268.2 |
Formula | C10H7F3N6 |
CAS No. | 56173-05-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
PCAF-IN-2 56173-05-8 inhibitor inhibit